Company: IMNN
Filing Date: 2025-05-20
Form Type: 8-K
Source: 0001641172-25-011601
Chunk: 0

Company: Imunon, Inc.
Filing Date: 2025-05-20
Form: 8-K
Item: Item 3.01
Chunk 0
---
Item
3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On
May 19, 2025, Imunon, Inc. (“the Company”) received a letter (the “ Notice”) from the staff (the “ Staff”)
of The Nasdaq Stock Market LLC (“ Nasdaq”) indicating that it is no longer in compliance with the minimum stockholders’
equity requirement (the “ Minimum Stockholders’ Equity Requirement”) for continued listing on The Nasdaq Capital Market
pursuant to Nasdaq Listing Rule 5550(b)(1). Nasdaq Listing Rule 5550(b)(1) requires listed companies to maintain stockholders’
equity of at least $2,500,000 or meet the alternative compliance standards relating to the market value of listed securities or net income
from continuing operations, which the Company does not currently meet.

Nasdaq’s
notice has no immediate effect on the listing of the Company’s common stock on The Nasdaq Capital Market, which continues to trade
under the symbol “ IMNN”.

Pursuant
to the Notice and the Listing Rules of Nasdaq, Nasdaq has provided the Company with 45 calendar days, or until July 3, 2025, to submit
a plan to regain compliance with the Minimum Stockholders’ Equity Requirement. If the Company’s plan to regain compliance
is accepted, the Staff can grant an extension of up to 180 calendar days from the date of the Notice to evidence compliance. If the Company’s
plan to regain compliance is not accepted, or if it is accepted and the Company does not regain compliance in the timeframe required
by Nasdaq, the Staff could provide notice that the Company’s shares of common stock are subject to delisting. In such an event,
the Company would have the right to request a hearing before a Nasdaq Hearings Panel.

The
Company is currently evaluating options to regain compliance and intends to timely submit a plan to regain compliance with the Minimum
Stockholders’ Equity Requirement. Although the Company intends to use all reasonable efforts to achieve compliance with the Minimum
Stockholders’ Equity Requirement, there can be no assurance that the Company will be able to regain compliance with the Minimum
Stockholders’ Equity Requirement or that the Company will otherwise be in compliance with other applicable Nasdaq listing criteria.

This
Current Report on Form 8-K is filed to satisfy the obligation under Nasdaq Listing Rule 5810(b) and Item 3